Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2008 6
2009 6
2010 7
2011 3
2012 3
2013 4
2014 2
2015 6
2016 2
2018 3
2019 3
2020 3
2023 2
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Effects of lactotripeptide ingestion and physical activity intervention on the fatigue status of middle-aged and older adults: a randomized controlled trial.
Yoshioka M, Kaneko T, Yoneko K, Matsui M, Mori S, Nishitani N, Wenxing Q, Ouchi K, Yasuda R, Namatame H, Sato T, Park J, Nakata Y, Maeda S, Kosaki K. Yoshioka M, et al. Sci Rep. 2023 Sep 21;13(1):15736. doi: 10.1038/s41598-023-41669-2. Sci Rep. 2023. PMID: 37735182 Free PMC article. Clinical Trial.
This randomized controlled trial aimed to investigate the effects of eight weeks of lactotripeptide (LTP) ingestion, physical activity (PA) intervention, and combined intervention on the fatigue status of middle-aged and older adults. ...
This randomized controlled trial aimed to investigate the effects of eight weeks of lactotripeptide (LTP) ingestion, physical activit …
Lactotripeptide ingestion increases cerebral blood flow velocity in middle-aged and older adults.
Akazawa N, Hamasaki A, Tanahashi K, Kosaki K, Yoshikawa T, Myoenzono K, Maeda S. Akazawa N, et al. Nutr Res. 2018 May;53:61-66. doi: 10.1016/j.nutres.2018.03.009. Epub 2018 Mar 23. Nutr Res. 2018. PMID: 29703414 Clinical Trial.
Milk protein-derived bioactive peptides, e.g., lactotripeptide (LTP), have been shown to inhibit angiotensin converting enzyme activities and increase vasodilator production. ...
Milk protein-derived bioactive peptides, e.g., lactotripeptide (LTP), have been shown to inhibit angiotensin converting enzyme activi …
Effects of Lactotripeptide Supplementation on Tele-Monitored Home Blood Pressure and on Vascular and Renal Function in Prehypertension - Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study.
Tomiyama H, Fujii M, Shiina K, Ueda SI, Iwasaki Y, Matsumoto C, Chikamori T. Tomiyama H, et al. Circ Rep. 2019 Oct 2;1(10):438-444. doi: 10.1253/circrep.CR-19-0061. Circ Rep. 2019. PMID: 33693081 Free PMC article.
Home systolic and diastolic BP at the end of the lactotripeptide supplementation period was significantly lower than that at the end of the placebo period (P<0.05). ...UFABPCR was significantly lower at the end of the lactotripeptide intervention period than at t …
Home systolic and diastolic BP at the end of the lactotripeptide supplementation period was significantly lower than that at the end …
Combined effects of lactotripeptide and aerobic exercise on cognitive function and cerebral oxygenation in middle-aged and older adults.
Hamasaki A, Akazawa N, Yoshikawa T, Myoenzono K, Tanahashi K, Sawano Y, Nakata Y, Maeda S. Hamasaki A, et al. Am J Clin Nutr. 2019 Feb 1;109(2):353-360. doi: 10.1093/ajcn/nqy235. Am J Clin Nutr. 2019. PMID: 30624594 Free article. Clinical Trial.
Although nutrition and exercise may be effective in reducing cognitive decline, the effect of lactotripeptide (LTP) on cerebral oxygenation and hemodynamics remains unclear. OBJECTIVES: The aim of this study was to investigate the effects of LTP ingestion on cerebral oxyge …
Although nutrition and exercise may be effective in reducing cognitive decline, the effect of lactotripeptide (LTP) on cerebral oxyge …
A 90-day subchronic toxicity study and reproductive toxicity studies on ACE-inhibiting lactotripeptide.
Dent MP, O'Hagan S, Braun WH, Schaetti P, Marburger A, Vogel O. Dent MP, et al. Food Chem Toxicol. 2007 Aug;45(8):1468-77. doi: 10.1016/j.fct.2007.02.006. Epub 2007 Feb 17. Food Chem Toxicol. 2007. PMID: 17383063
This has led to the use of these tripeptides, collectively referred to as lactotripeptide (LTP) as ingredients of functional foods intended to help control blood pressure. ...
This has led to the use of these tripeptides, collectively referred to as lactotripeptide (LTP) as ingredients of functional foods in …
[Survey of Label Information of Foods with Function Claims].
Mori M, Shimauchi A, Yajima S, Nishio H, Tamaki H, Sakai C, Osanai A, Ino Y, Teramachi H, Nakamura M, Iguchi K. Mori M, et al. Yakugaku Zasshi. 2020;140(3):443-448. doi: 10.1248/yakushi.19-00156. Yakugaku Zasshi. 2020. PMID: 32115567 Free article. Review. Japanese.
In this study, we checked the items described on the packaging of Foods with Function Claims containing eicosapentaenoic acid (EPA) and/or docosahexaenoic acid (DHA), Salacinol/Fagomine/Neokotalanol, or Varyl-Tyrosine/Lactotripeptide. We found that the label information on …
In this study, we checked the items described on the packaging of Foods with Function Claims containing eicosapentaenoic acid (EPA) and/or d …
Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation.
Foltz M, Meynen EE, Bianco V, van Platerink C, Koning TM, Kloek J. Foltz M, et al. J Nutr. 2007 Apr;137(4):953-8. doi: 10.1093/jn/137.4.953. J Nutr. 2007. PMID: 17374660 Free article. Clinical Trial.
The aim of this placebo-controlled crossover study was to assess the bioavailability of Ile-Pro-Pro and 7 other ACE-inhibiting peptides present in a lactotripeptide (LTP)-enriched yogurt beverage and whether meal intake affects Ile-Pro-Pro bioavailability. ...
The aim of this placebo-controlled crossover study was to assess the bioavailability of Ile-Pro-Pro and 7 other ACE-inhibiting peptides pres …
Antihypertensive Peptides from Milk Proteins.
Jäkälä P, Vapaatalo H. Jäkälä P, et al. Pharmaceuticals (Basel). 2010 Jan 19;3(1):251-272. doi: 10.3390/ph3010251. Pharmaceuticals (Basel). 2010. PMID: 27713251 Free PMC article. Review.
During the fermentation of milk with certain lactobacilli, two interesting tripeptides Ile-Pro-Pro and Val-Pro-Pro are released from casein to the final product. These lactotripeptides have attenuated the development of hypertension in several animal models and lowered blo …
During the fermentation of milk with certain lactobacilli, two interesting tripeptides Ile-Pro-Pro and Val-Pro-Pro are released from casein …
Lactotripeptides and antihypertensive effects: a critical review.
Boelsma E, Kloek J. Boelsma E, et al. Br J Nutr. 2009 Mar;101(6):776-86. doi: 10.1017/S0007114508137722. Epub 2008 Dec 5. Br J Nutr. 2009. PMID: 19061526 Review.
This paper reviews the current evidence of the blood pressure control properties of lactotripeptides in man. Blood pressure-lowering effects of lactotripeptides are typically measured after 4-6 weeks of treatment. ...Concomitant intake of antihypertensive medication …
This paper reviews the current evidence of the blood pressure control properties of lactotripeptides in man. Blood pressure-lowering …
Lactopeptides and human blood pressure.
Geleijnse JM, Engberink MF. Geleijnse JM, et al. Curr Opin Lipidol. 2010 Feb;21(1):58-63. doi: 10.1097/MOL.0b013e3283333813. Curr Opin Lipidol. 2010. PMID: 19884823 Review.
This review was performed to summarize new data from human intervention studies. RECENT FINDINGS: The effect of lactotripeptides on blood pressure has recently been examined in six double-blind, placebo-controlled trials that involved a total of 780 subjects with high-norm …
This review was performed to summarize new data from human intervention studies. RECENT FINDINGS: The effect of lactotripeptides on b …
45 results